Back

DNA methylation-based prediction of differentiation state at cell-type resolution reveals an age-associated epigenetic mesenchymal drift

Teschendorff, A.; Tong, H.; Guo, X.

2026-10-11 bioinformatics
10.64898/2026.10.10.758162 bioRxiv
Show abstract

Quantifying the differentiation state of cells is an important task in regenerative medicine, cellular reprogramming and in elucidating how differentiation hierarchies are altered in aging and disease. For DNA methylation data (DNAm) there is however an accute shortage of methods for quantifying differentiation state. Here we use machine learning to build EpiDiff, a predictor of differentiation that yields a continuous absolute differentiation index (DI) when applied to a DNAm sample. We extensively validate EpiDiff in single-cells, sorted cells and bulk tissue, as well as in in-vitro differentiation, organoid, reprogramming and cellular rejuvenation experiments. In mixed samples, EpiDiff measures the extent of differentiation across all cellular lineages. In sorted cell populations, we find that DI increases with age and, underpinning this increase, we discover that many cell-types undergo a developmental epigenetic drift that is most prominent towards the mesenchymal lineage. When applied to normal-tissues, EpiDiff is predictive of carcinogenic exposure and cancer risk. In summary, EpiDiff is a unique, general and versatile tool that can accurately quantify the global differentiation state of a DNAm sample with broad applicability to many disciplines.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.